Skip to content

SANUWAVE Health, Inc. SNWV Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

ePlus logo
ePlusPLUS
$1.85M+1.4%
RGC Resources logo
RGC ResourcesRGCO
$1.04M+135%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$1.8M-40.0%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$69.99M
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
$7.56M+443%
Whirlpool logo
WhirlpoolWHR
$524M

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: SANUWAVE Health, Inc.’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s stock issuance proceeds?
SANUWAVE Health, Inc. (SNWV) reported stock issuance proceeds of $0 in Q4 2025.
How has SANUWAVE Health, Inc.'s stock issuance proceeds changed year-over-year?
SANUWAVE Health, Inc.'s stock issuance proceeds decreased by 100.0% year-over-year, from $2.58M to $0.
What does stock issuance proceeds mean?
This represents the cash proceeds received from the sale of new common equity shares to investors. It serves as a primary indicator of the company's ability to raise external capital to fund operations or strategic initiatives.